TWFG Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction ATKR Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Execution ESPR Q1 2026 Earnings EPS Misses Estimates as Revenue Goes Unreported Kalaris Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid PreRevenue Biotech FCNCN Q1 2026 Earnings Strong EPS Beat Driven by Higher Net Interest Income Intensity Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Clinical Progress